• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年龄相关的低密度脂蛋白胆固醇与动脉粥样硬化性心血管疾病的关系:一项全国范围内基于人群的队列研究。

Age-Related Associations of Low-Density Lipoprotein Cholesterol and Atherosclerotic Cardiovascular Disease: A Nationwide Population-Based Cohort Study.

机构信息

Department of Internal Medicine Asan Medical CenterUniversity of Ulsan College of Medicine Seoul Republic of Korea.

Asan Diabetes Center Asan Medical Center Seoul Republic of Korea.

出版信息

J Am Heart Assoc. 2022 May 3;11(9):e024637. doi: 10.1161/JAHA.121.024637. Epub 2022 May 2.

DOI:10.1161/JAHA.121.024637
PMID:35492003
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9238630/
Abstract

Background The relationship between low-density lipoprotein cholesterol (LDL-C) and atherosclerotic cardiovascular disease (ASCVD) according to age remains undetermined. Thus, this study aimed to investigate the age-related association of LDL-C and ASCVD. Methods and Results Data from the Korean NHIS-HEALS (National Health Insurance Service-National Health Screening Cohort) were analyzed. Individuals previously diagnosed with cardiovascular disease or taking lipid-lowering drugs were excluded. Age-specific association between LDL-C and ASCVD was calculated using adjusted Cox proportional hazards models. During a median follow-up of 6.44 years for 285 119 adults, ASCVD developed in 8996 (3.2%). All age groups showed positive associations between LDL-C and ASCVD risk, mostly with statistical significance from LDL-C of 160 mg/dL onward. ASCVD risk did not differ significantly between the age groups ( for interaction=0.489). Correspondingly, subgroup analysis in type 2 diabetes exhibited no difference in the age-specific association of LDL-C and ASCVD ( for interaction=0.784). Conclusions The study demonstrated that people aged ≥75 years with higher LDL-C at baseline still presented increased ASCVD risk, which was not significantly different from the younger groups. These findings support the importance of managing LDL-C for the prevention of primary ASCVD in the growing elderly population.

摘要

背景

低密度脂蛋白胆固醇(LDL-C)与动脉粥样硬化性心血管疾病(ASCVD)的关系随年龄而变化,但目前尚不确定。因此,本研究旨在探讨 LDL-C 与 ASCVD 之间的年龄相关性。

方法和结果

对韩国 NHIS-HEALS(国家健康保险服务-国家健康筛查队列)的数据进行了分析。排除了既往患有心血管疾病或服用降脂药物的个体。使用校正的 Cox 比例风险模型计算了 LDL-C 与 ASCVD 之间的年龄特异性相关性。在 285119 名成年人的中位随访 6.44 年期间,有 8996 人(3.2%)发生 ASCVD。所有年龄组的 LDL-C 与 ASCVD 风险之间均呈正相关,且大多数相关性在 LDL-C 达到 160mg/dL 后具有统计学意义。各年龄组之间 ASCVD 风险无显著差异(交互作用=0.489)。相应地,2 型糖尿病亚组分析显示 LDL-C 和 ASCVD 的年龄特异性相关性无差异(交互作用=0.784)。

结论

本研究表明,基线时 LDL-C 较高的≥75 岁人群仍存在 ASCVD 风险增加,且与年轻人群无显著差异。这些发现支持在不断增长的老年人群中,通过控制 LDL-C 来预防原发性 ASCVD 的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b811/9238630/2e54234102da/JAH3-11-e024637-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b811/9238630/7900edb78938/JAH3-11-e024637-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b811/9238630/2e54234102da/JAH3-11-e024637-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b811/9238630/7900edb78938/JAH3-11-e024637-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b811/9238630/2e54234102da/JAH3-11-e024637-g001.jpg

相似文献

1
Age-Related Associations of Low-Density Lipoprotein Cholesterol and Atherosclerotic Cardiovascular Disease: A Nationwide Population-Based Cohort Study.年龄相关的低密度脂蛋白胆固醇与动脉粥样硬化性心血管疾病的关系:一项全国范围内基于人群的队列研究。
J Am Heart Assoc. 2022 May 3;11(9):e024637. doi: 10.1161/JAHA.121.024637. Epub 2022 May 2.
2
Discordance Between Very Low-Density Lipoprotein Cholesterol and Low-Density Lipoprotein Cholesterol Increases Cardiovascular Disease Risk in a Geographically Defined Cohort.极低密度脂蛋白胆固醇与低密度脂蛋白胆固醇不匹配会增加特定地区人群的心血管疾病风险。
J Am Heart Assoc. 2024 Apr 16;13(8):e031878. doi: 10.1161/JAHA.123.031878. Epub 2024 Apr 9.
3
The Association Between Low-Density Lipoprotein Cholesterol and Incident Atherosclerotic Cardiovascular Disease in Older Adults: Results From the National Institutes of Health Pooled Cohorts.低密度脂蛋白胆固醇与老年人动脉粥样硬化性心血管疾病事件的相关性:来自美国国立卫生研究院荟萃队列的研究结果。
J Am Geriatr Soc. 2019 Dec;67(12):2560-2567. doi: 10.1111/jgs.16123. Epub 2019 Aug 14.
4
Incremental Benefit of Lipid Lowering in a Large Chinese Population Aged 75 Years and Older With Established Atherosclerotic Cardiovascular Disease.降脂治疗在中国 75 岁及以上伴有动脉粥样硬化性心血管疾病的大人群中的获益递增。
Mayo Clin Proc. 2023 Sep;98(9):1280-1296. doi: 10.1016/j.mayocp.2023.06.003.
5
Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.降低“极高”ASCVD 风险患者的靶向致动脉粥样硬化脂蛋白胆固醇目标。
Curr Diab Rep. 2019 Nov 21;19(12):146. doi: 10.1007/s11892-019-1246-y.
6
Low-Density Lipoprotein Cholesterol, Cardiovascular Disease Risk, and Mortality in China.低密度脂蛋白胆固醇、心血管疾病风险与中国人群死亡
JAMA Netw Open. 2024 Jul 1;7(7):e2422558. doi: 10.1001/jamanetworkopen.2024.22558.
7
Associations of LDL Cholesterol, Non-HDL Cholesterol, and Apolipoprotein B With Cardiovascular Disease Occurrence in Adults: Korean Genome and Epidemiology Study.载脂蛋白 B 与 LDL 胆固醇、非 HDL 胆固醇与成年人心血管疾病发病风险的相关性:韩国基因组与流行病学研究。
Ann Lab Med. 2023 May 1;43(3):237-243. doi: 10.3343/alm.2023.43.3.237. Epub 2022 Dec 22.
8
Childhood Non-HDL Cholesterol and LDL Cholesterol and Adult Atherosclerotic Cardiovascular Events.儿童非高密度脂蛋白胆固醇和低密度脂蛋白胆固醇与成人动脉粥样硬化性心血管事件。
Circulation. 2024 Jan 16;149(3):217-226. doi: 10.1161/CIRCULATIONAHA.123.064296. Epub 2023 Nov 28.
9
Serum Low-Density Lipoprotein Cholesterol and Cardiovascular Disease Risk Across Chronic Kidney Disease Stages (Data from 1.9 Million United States Veterans).血清低密度脂蛋白胆固醇与慢性肾脏病各期的心血管疾病风险(来自 190 万美国退伍军人的数据)。
Am J Cardiol. 2022 May 1;170:47-55. doi: 10.1016/j.amjcard.2022.01.034. Epub 2022 Mar 15.
10
Twenty-year epidemiologic study on LDL-C levels in relation to the risks of atherosclerotic event, hemorrhagic stroke, and cancer death among young and middle-aged population in China.中国青年和中年人群 LDL-C 水平与动脉粥样硬化事件、出血性卒中和癌症死亡风险的 20 年流行病学研究。
J Clin Lipidol. 2018 Sep-Oct;12(5):1179-1189.e4. doi: 10.1016/j.jacl.2018.06.011. Epub 2018 Jun 26.

引用本文的文献

1
Unraveling the role of cumulative triglyceride-total cholesterol-body weight index in stroke development: evidence from the CHARLS cohort.解析累积甘油三酯-总胆固醇-体重指数在中风发生中的作用:基于中国健康与养老追踪调查(CHARLS)队列的证据
Front Med (Lausanne). 2025 Jul 10;12:1616520. doi: 10.3389/fmed.2025.1616520. eCollection 2025.
2
Impact of age on clinical characteristics and 1-year outcomes of non-disabling ischemic cerebrovascular events: A multicenter prospective cohort study.年龄对非致残性缺血性脑血管事件的临床特征和 1 年结局的影响:一项多中心前瞻性队列研究。
BMC Geriatr. 2024 Oct 26;24(1):884. doi: 10.1186/s12877-024-05491-3.
3

本文引用的文献

1
2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in Adults.2021 加拿大心血管学会成人血脂异常管理指南:预防心血管疾病
Can J Cardiol. 2021 Aug;37(8):1129-1150. doi: 10.1016/j.cjca.2021.03.016. Epub 2021 Mar 26.
2
Differential Effect of Metabolic Health and Obesity on Incident Heart Failure: A Nationwide Population-Based Cohort Study.代谢健康和肥胖对心力衰竭发生率的影响差异:一项全国范围内基于人群的队列研究。
Front Endocrinol (Lausanne). 2021 Feb 25;12:625083. doi: 10.3389/fendo.2021.625083. eCollection 2021.
3
Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association.
Reduced circulating CD63 extracellular vesicle levels associate with atherosclerosis in hypercholesterolaemic mice and humans.
循环 CD63 外泌体水平降低与高胆固醇血症小鼠和人类的动脉粥样硬化有关。
Cardiovasc Diabetol. 2024 Oct 17;23(1):368. doi: 10.1186/s12933-024-02459-w.
4
The onset and the development of cardiometabolic aging: an insight into the underlying mechanisms.心脏代谢衰老的发生与发展:对潜在机制的深入洞察。
Front Pharmacol. 2024 Sep 26;15:1447890. doi: 10.3389/fphar.2024.1447890. eCollection 2024.
心脏病与中风统计-2021 更新:美国心脏协会报告。
Circulation. 2021 Feb 23;143(8):e254-e743. doi: 10.1161/CIR.0000000000000950. Epub 2021 Jan 27.
4
Efficacy and safety of lowering LDL cholesterol in older patients: a systematic review and meta-analysis of randomised controlled trials.降低老年患者 LDL 胆固醇的疗效和安全性:一项随机对照试验的系统评价和荟萃分析。
Lancet. 2020 Nov 21;396(10263):1637-1643. doi: 10.1016/S0140-6736(20)32332-1. Epub 2020 Nov 10.
5
Association of Statin Use With Disability-Free Survival and Cardiovascular Disease Among Healthy Older Adults.他汀类药物的使用与健康老年人的无残疾生存和心血管疾病的关系。
J Am Coll Cardiol. 2020 Jul 7;76(1):17-27. doi: 10.1016/j.jacc.2020.05.016.
6
Effects of Statins on Memory, Cognition, and Brain Volume in the Elderly.他汀类药物对老年人记忆力、认知能力和大脑体积的影响。
J Am Coll Cardiol. 2019 Nov 26;74(21):2554-2568. doi: 10.1016/j.jacc.2019.09.041.
7
Effect of alirocumab on cardiovascular outcomes after acute coronary syndromes according to age: an ODYSSEY OUTCOMES trial analysis.根据年龄分析阿利西尤单抗对急性冠状动脉综合征后心血管结局的影响:一项ODYSSEY OUTCOMES试验分析。
Eur Heart J. 2020 Jun 21;41(24):2248-2258. doi: 10.1093/eurheartj/ehz809.
8
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.2019年欧洲心脏病学会/欧洲动脉粥样硬化学会血脂异常管理指南:通过血脂修饰降低心血管风险
Eur Heart J. 2020 Jan 1;41(1):111-188. doi: 10.1093/eurheartj/ehz455.
9
Implications of the dynamic nature of metabolic health status and obesity on risk of incident cardiovascular events and mortality: a nationwide population-based cohort study.代谢健康状况和肥胖的动态性质对心血管事件和死亡发生风险的影响:一项全国性基于人群的队列研究。
Metabolism. 2019 Aug;97:50-56. doi: 10.1016/j.metabol.2019.05.002. Epub 2019 May 7.
10
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2019美国心脏病学会/美国心脏协会心血管疾病一级预防指南:美国心脏病学会/美国心脏协会临床实践指南工作组报告
Circulation. 2019 Sep 10;140(11):e596-e646. doi: 10.1161/CIR.0000000000000678. Epub 2019 Mar 17.